aminopropionitrile and oltipraz
aminopropionitrile has been researched along with oltipraz in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Chen, X; Du, X; Huang, X; Le, S; Li, R; Luo, J; Song, Y; Wang, D; Wang, H; Wu, J; Wu, L; Ye, P | 1 |
Other Studies
1 other study(ies) available for aminopropionitrile and oltipraz
Article | Year |
---|---|
Oltipraz, the activator of nuclear factor erythroid 2-related factor 2 (Nrf2), protects against the formation of BAPN-induced aneurysms and dissection of the thoracic aorta in mice by inhibiting activation of the ROS-mediated NLRP3 inflammasome.
Topics: Aminopropionitrile; Aneurysm; Animals; Aorta, Thoracic; Inflammasomes; Mice; NF-E2-Related Factor 2; NLR Family, Pyrin Domain-Containing 3 Protein; Reactive Oxygen Species | 2022 |